PureTech Health plc (OTCMKTS:PTCHF) Short Interest Down 60.3% in December

PureTech Health plc (OTCMKTS:PTCHF) was the target of a significant decline in short interest during the month of December. As of December 31st, there was short interest totalling 6,000 shares, a decline of 60.3% from the December 15th total of 15,100 shares. Based on an average daily volume of 3,300 shares, the short-interest ratio is currently 1.8 days.

PureTech Health Stock Down 15.4 %

Shares of OTCMKTS:PTCHF traded down $0.31 on Monday, reaching $1.69. 14,534 shares of the company traded hands, compared to its average volume of 30,830. PureTech Health has a 52 week low of $1.69 and a 52 week high of $3.00. The business’s 50-day simple moving average is $2.07 and its 200 day simple moving average is $2.06.

PureTech Health Company Profile

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.